B
PRCT icon

Bayban’s Procept Biorobotics PRCT Stock Holding History

Bayban’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$452 Hold
20
– – ﹤0.01% 582
2026
Q1 		$500 Hold
20
– – ﹤0.01% 652
2025
Q4 		$629 Buy
+20
New +$663 ﹤0.01% 590

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Bayban's PRCT Position: Q2 2026 in Review

Bayban held its Procept Biorobotics (PRCT) position steady in Q2 2026 at 20 shares worth $452. The position accounts for ﹤0.01% of the portfolio, ranked #582.

Bayban first reported a position in PRCT in Q4 2025 and has held it in 3 quarters since. The position peaked at $629 in Q4 2025. 238 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Bayban held 20 shares of Procept Biorobotics worth $452 as of Q2 2026.
  • Bayban left its Procept Biorobotics share count unchanged in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of Bayban's portfolio in Q2 2026, its #582 holding.
  • Bayban first reported a position in Procept Biorobotics in Q4 2025 and has held it in 3 quarters since.
  • Bayban's Procept Biorobotics position peaked at $629 in Q4 2025.
  • 238 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.